Lessee, Operating Lease, Liability, to be Paid, Year Three of Citius Pharmaceuticals, Inc. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Citius Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • Citius Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Sep 2025 was $237,686.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)

Citius Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $237,686 30 Sep 2025 10-K 23 Dec 2025 2025 FY
Q2 2025 $237,686 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 $237,686 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q3 2023 $21,460 30 Sep 2023 10-K 29 Dec 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.